Экзема

Sidbury R, Tom WL, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014 Dec;71(6):1218-33.Полный текст  Аннотация

Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb;70(2):338-51.Полный текст  Аннотация

van Zuuren EJ, Fedorowicz Z, Christensen R, et al. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017 Feb 6;(2):CD012119.Полный текст  Аннотация

Sidbury R, Davis DM, Cohen DE, et al; American Academy of Dermatology. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014 Aug;71(2):327-49.Полный текст  Аннотация

Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014 Jul;71(1):116-32.Полный текст  Аннотация

1. Spergel JM, Paller AS. Atopic dermatitis and the atopic march. J Allergy Clin Immunol. 2003 Dec;112(6 Suppl):S118-27. Аннотация

2. Kim JP, Chao LX, Simpson EL, et al. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016 Oct;75(4):681-87;e11.Полный текст  Аннотация

3. Chopra R, Vakharia PP, Sacotte R, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017 Nov;177(5):1316-21. Аннотация

4. National Institute for Health and Care Excellence. Dupilumab for treating moderate to severe atopic dermatitis. August 2018 [internet publication].Полный текст

5. Agache I, Akdis CA, Akdis M, et al. EAACI biologicals guidelines: dupilumab for children and adults with moderate-to-severe atopic dermatitis. Allergy. 2021 Apr;76(4):988-1009. Аннотация

6. Williams H. Atopic Dermatitis. N Engl J Med. 2005 Jun 2;352(22):2314-24. Аннотация

7. Paller AS, Mancini J. Hurwitz clinical pediatric dermatology: a textbook of skin disorders of childhood and adolescence. 5th ed. Philadelphia, PA: Elsevier Saunders; 2016.

8. Hirano SA, Murray SB, Harvey VM. Reporting, representation, and subgroup analysis of race and ethnicity in published clinical trials of atopic dermatitis in the United States between 2000 and 2009. Pediatr Dermatol. 2012 Nov-Dec;29(6):749-55. Аннотация

9. Leung D, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. The J Clin Invest. 2004 Mar;113(5):651-7.Полный текст  Аннотация

10. Chiesa Fuxench ZC, Block JK, Boguniewicz M, et al. Atopic dermatitis in America study: a cross-sectional study examining the prevalence and disease burden of atopic dermatitis in the US adult population. J Invest Dermatol. 2019 Mar;139(3):583-90.Полный текст  Аннотация

11. Silverberg JI, Gelfand JM, Margolis DJ, et al. Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018 Sep;121(3):340-7.Полный текст  Аннотация

12. Bylund S, von Kobyletzki LB, Svalstedt M, et al. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol. 2020 Jun 9;100(12):adv00160.Полный текст  Аннотация

13. Flohr C, Yeo L. Atopic dermatitis and the hygiene hypothesis revisited. Curr Probl Dermatol. 2011;41:1-34. Аннотация

14. Morar N, Cookson W, Harper JI, et al. Filaggrin Mutations in Children with Severe Atopic Dermatitis. J Invest Dermatol. 2007 Jul;127(7):1667-72.Полный текст  Аннотация

15. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006 Apr;38(4):441-6. Аннотация

16. Meagher LJ, Wines NY, Cooper AJ. Atopic dermatitis: review of immunopathogenesis and advances in immunosuppressive therapy. Australas J Dermatol. 2002 Nov;43(4):247-54. Аннотация

17. McLean WH. Filaggrin failure: from ichthyosis vulgaris to atopic eczema and beyond. Br J Dermatol. 2016 Oct;175 Suppl 2(Suppl 2):4-7.Полный текст  Аннотация

18. McGrath JA. Filaggrin and the great epidermal barrier grief. Australas J Dermatol. 2008 May;49(2):67-73; quiz 73-4. Аннотация

19. Kantor R, Silverberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol. 2017 Jan;13(1):15-26.Полный текст  Аннотация

20. Tamagawa-Mineoka R, Katoh N. Atopic dermatitis: identification and management of complicating factors. Int J Mol Sci. 2020 Apr 11;21(8):2671.Полный текст  Аннотация

21. Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship. Trends Microbiol. 2018 Jun;26(6):484-97. Аннотация

22. Howell MD, Kim BE, Gao P, et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol. 2007 Jul;120(1):150-5. Аннотация

23. Løset M, Brown SJ, Saunes M, et al. Genetics of atopic dermatitis: from DNA sequence to clinical relevance. Dermatology. 2019;235(5):355-64.Полный текст  Аннотация

24. Carlsten C, Dimich-Ward H, Ferguson A, et al. Atopic dermatitis in a high-risk cohort: natural history, associated allergic outcomes, and risk factors. Ann Allergy Asthma Immunol. 2013 Jan;110(1):24-8. Аннотация

25. Schultz Larsen F, Diepgen T, Svensson A. The occurrence of atopic dermatitis in north Europe: an international questionnaire study. J Am Acad Dermatol. 1996 May;34(5 pt 1):760-4. Аннотация

26. Kantor R, Kim A, Thyssen JP, et al. Association of atopic dermatitis with smoking: a systematic review and meta-analysis. J Am Acad Dermatol. 2016 Dec;75(6):1119-25;e1.Полный текст  Аннотация

27. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD000133.Полный текст  Аннотация

28. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Evid Based Child Health. 2014 Jun;9(2):447-83. Аннотация

29. Cuello-Garcia CA, Brożek JL, Fiocchi A, et al. Probiotics for the prevention of allergy: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2015 Oct;136(4):952-61. Аннотация

30. Makrgeorgou A, Leonardi-Bee J, Bath-Hextall FJ, et al. Probiotics for treating eczema. Cochrane Database Syst Rev. 2018 Nov 21;(11):CD006135.Полный текст  Аннотация

31. Tan-Lim CSC, Esteban-Ipac NAR, Recto MST, et al. Comparative effectiveness of probiotic strains on the prevention of pediatric atopic dermatitis: a systematic review and network meta-analysis. Pediatr Allergy Immunol. 2021 Aug;32(6):1255-70. Аннотация

32. Kelleher MM, Cro S, Cornelius V, et al. Skin care interventions in infants for preventing eczema and food allergy. Cochrane Database Syst Rev. 2021 Feb 5;2(2):CD013534.Полный текст  Аннотация

33. Sidbury R, Tom WL, Bergman JN, et al. Guidelines of care for the management of atopic dermatitis: section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014 Dec;71(6):1218-33.Полный текст  Аннотация

34. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014 Feb;70(2):338-51.Полный текст  Аннотация

35. Eigenmann PA, Sicherer SH, Borkowski TA, et al. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics. 1998 Mar;101(3):E8.Полный текст  Аннотация

36. Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018 May;32(5):657-82.Полный текст  Аннотация

37. Beattie PE, Green C, Lowe G, et al. Which children should we patch test? Clin Exp Dermatol. 2007 Jan;32(1):6-11. Аннотация

38. Milingou M, Tagka A, Armenaka M, et al. Patch tests in children: a review of 13 years of experience in comparison with previous data. Pediatr Dermatol. 2010 May-Jun;27(3):255-9. Аннотация

39. Pigatto P, Martelli A, Marsili C, et al. Contact dermatitis in children. Ital J Pediatr. 2010 Jan 13;36:2.Полный текст  Аннотация

40. Owen JL, Vakharia PP, Silverberg JI. The role and diagnosis of allergic contact dermatitis in patients with atopic dermatitis. Am J Clin Dermatol. 2018 Jun;19(3):293-302.Полный текст  Аннотация

41. Jacob SE, Burk CJ, Connelly EA. Patch testing: another steroid-sparing agent to consider in children. Pediatr Dermatol. 2008 Jan-Feb;25(1):81-7. Аннотация

42. Barnetson R, Rogers M. Childhood atopic eczema. BMJ. 2002 Jun 8;324(7350):1376-9. Аннотация

43. Piloto Valdés L, Gómez Echevarría AH, Valdés Sánchez AF, et al. Atopic dermatitis: findings of skin biopsies. Allergol Immunopathol (Madr). 1990 Nov-Dec;18(6):321-4. Аннотация

44. Weinstock MA, Horm JW. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. JAMA. 1988 Jul 1;260(1):42-6. Аннотация

45. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol Vereneol. 1980;92(suppl):44-47.

46. De D, Kanwar AJ, Handa S. Comparative efficacy of Hanifin and Rajka's criteria and the UK working party's diagnostic criteria in diagnosis of atopic dermatitis in a hospital setting in North India. JEADV. 2006 Aug;20(7):853-9. Аннотация

47. Vakharia PP, Chopra R, Silverberg JI. Systematic review of diagnostic criteria used in atopic dermatitis randomized controlled trials. Am J Clin Dermatol. 2018 Feb;19(1):15-22. Аннотация

48. Johnke H, Vach W, Norberg LA, et al. A comparison between criteria for diagnosing atopic eczema in infants. Br J Dermatol. 2005 Aug;153(2):352-8. Аннотация

49. Williams HC, Burney PG, Pembroke AC, et al. Validation of the U.K. diagnostic criteria for atopic dermatitis in a population setting. Br J Dermatol. 1996 Jul;135(1):12-7. Аннотация

50. Williams HC, Burney PG, Hay RJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994 Sep;131(3):383-96. Аннотация

51. Fleming S, Bodner C, Devereux G, et al. An application of the United Kingdom Working Party diagnostic criteria for atopic dermatitis in Scottish infants. J Invest Dermatol. 2001 Dec;117(6):1526-30. Аннотация

52. Levy ML. Atopic dermatitis: understanding the disease and its management. Curr Med Res Opin. 2007 Dec;23(12):3091-103. Аннотация

53. Darsow U, Wollenberg A, Simon D, et al. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 2010 Mar;24(3):317-28.Полный текст  Аннотация

54. Simpson EL. Atopic dermatitis: a review of topical treatment options. Cur Med Res Opin. 2010 Mar;26(3):633-40. Аннотация

55. Kosse RC, Bouvy ML, Daanen M, et al. Adolescents' perspectives on atopic dermatitis treatment-experiences, preferences, and beliefs. JAMA Dermatol. 2018 Jul 1;154(7):824-7.Полный текст  Аннотация

56. van Zuuren EJ, Fedorowicz Z, Christensen R, et al. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017 Feb 6;(2):CD012119.Полный текст  Аннотация

57. Sidbury R, Davis DM, Cohen DE, et al; American Academy of Dermatology. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014 Aug;71(2):327-49.Полный текст  Аннотация

58. Yu SH, Drucker AM, Lebwohl M, et al. A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis. J Am Acad Dermatol. 2018 Apr;78(4):733-40. Аннотация

59. Eckert L, Gupta S, Amand C, et al. Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: an analysis using the National Health and Wellness Survey. J Am Acad Dermatol. 2017 Aug;77(2):274-9.Полный текст  Аннотация

60. Teasdale E, Muller I, Sivyer K, et al. Views and experiences of managing eczema: systematic review and thematic synthesis of qualitative studies. Br J Dermatol. 2021 Apr;184(4):627-37.Полный текст  Аннотация

61. Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014 Jul;71(1):116-32.Полный текст  Аннотация

62. Czarnowicki T, Malajian D, Khattri S, et al. Petrolatum: barrier repair and antimicrobial responses underlying this "inert" moisturizer. J Allergy Clin Immunol. 2016 Apr;137(4):1091-102.Полный текст  Аннотация

63. Nicol NH, Boguniewicz M, Strand M, et al. Wet wrap therapy in children with moderate to severe atopic dermatitis in a multidisciplinary treatment program. J Allergy Clin Immunol Pract. Jul-Aug 2014;2(4):400-6. Аннотация

64. Del Rosso JQ, Bhambri S. Daily application of fluocinonide 0.1% cream for the treatment of atopic dermatitis. J Clin Aesthet Dermatol. 2009 Sep;2(9):24-32.Полный текст  Аннотация

65. El Hachem M, Gesualdo F, Ricci G, et al. Topical corticosteroid phobia in parents of pediatric patients with atopic dermatitis: a multicentre survey. Ital J Pediatr. 2017 Feb 28;43(1):22.Полный текст  Аннотация

66. Smith SD, Hong E, Fearns S, et al. Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups. Australas J Dermatol. 2010 Aug;51(3):168-74. Аннотация

67. Veenje S, Osinga H, Antonescu I, et al. Focus group parental opinions regarding treatment with topical corticosteroids on children with atopic dermatitis. Allergol Immunopathol (Madr). Mar-Apr 2019;47(2):166-71.Полный текст  Аннотация

68. Matheson R, Kempers S, Breneman D, et al. Hydrocortisone butyrate 0.1% lotion in the treatment of atopic dermatitis in pediatric subjects. J Drugs Dermatol. 2008 Mar;7(3):266-71. Аннотация

69. Wolverton SE. Comprehensive dermatologic drug therapy. 2nd ed. Philadelphia, PA: Elsevier Saunders; 2007.

70. Callen J, Chamlin S, Eichenfield LF, et al. A systematic review of the safety of topical therapies for atopic dermatitis. Br J Dermatol. 2007 Feb;156(2):203-21. Аннотация

71. Jeziorkowska R, Sysa-Jędrzejowska A, Samochocki Z. Topical steroid therapy in atopic dermatitis in theory and practice. Postepy Dermatol Alergol. 2015 Jun 10;32(3):162-6. Аннотация

72. Trookman NS, Rizer RL. Randomized controlled trial of desonlde hydrogel 0.05% versus desonide ointment 0.05% in the treatment of mild-to-moderate atopic dermatitis. J Clin Aesthet Dermatol. 2011 Nov;4(11):34-8.Полный текст  Аннотация

73. Sher LG, Chang J, Patel IB, et al. Relieving the pruritus of atopic dermatitis: a meta-analysis. Acta Derm Venereol. 2012 Sep;92(5):455-61. Аннотация

74. Cury Martins J, Martins C, Aoki V, et al. Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev. 2015 Jul 1;(7):CD009864.Полный текст  Аннотация

75. Paller AS, Fölster-Holst R, Chen SC, et al. No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis. J Am Acad Dermatol. 2020 Aug;83(2):375-81.Полный текст  Аннотация

76. Beck LA, Thaçi D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014 Jul 10;371(2):130-9.Полный текст  Аннотация

77. Yang H, Wang J, Zhang X, et al. Application of topical phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol. 2019 May 1;155(5):585-93.Полный текст  Аннотация

78. Draelos ZD, Stein Gold LF, Murrell DF, et al. Post hoc analyses of the effect of crisaborole topical ointment, 2% on atopic dermatitis: associated pruritus from phase 1 and 2 clinical studies. J Drugs Dermatol. 2016 Feb;15(2):172-6. Аннотация

79. Gong JQ, Lin L, Lin T, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006 Oct;155(4):680-7. Аннотация

80. Dickman M, Dawson AL, Dellavalle RP. The relationship between hygiene and microbial burden in atopic dermatitis risk based on a systematic review. Arch Dermatol. 2012 Aug;148(8):936-8. Аннотация

81. Anderson PC, Dinulos JG. Atopic dermatitis and alternative management strategies. Curr Opin Pediatr. 2009 Feb;21(1):131-8. Аннотация

82. Huang JT, Rademaker A, Paller AS. Dilute bleach baths for Staphylococcus aureus colonization in atopic dermatitis to decrease disease severity. Arch Dermatol. 2011 Feb;147(2):246-7. Аннотация

83. British Association of Dermatologists. Service guidance and standards for phototherapy units. October 2016 [internet publication].Полный текст

84. Elsner P, Agner T. Hand eczema: treatment. J Eur Acad Dermatol Venereol. 2020 Jan;34 Suppl 1:13-21.Полный текст  Аннотация

85. Simpson EL, Bruin-Weller M, Flohr C, et al. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. J Am Acad Dermatol. 2017 Oct;77(4):623-33.Полный текст  Аннотация

86. Agache I, Song Y, Posso M, et al. Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI biologicals guidelines. Allergy. 2021 Jan;76(1):45-58.Полный текст  Аннотация

87. Schmitt J, Schäkel K, Schmitt N, et al. Systemic treatment of severe atopic eczema: a systematic review. Acta Derm Venereol. 2007;87(2):100-11. Аннотация

88. Gooderham M, Lynde CW, Papp K, et al. Review of systemic treatment options for adult atopic dermatitis. J Cutan Med Surg. 2017 Jan/Feb;21(1):31-9. Аннотация

89. Siegels D, Heratizadeh A, Abraham S, et al. Systemic treatments in the management of atopic dermatitis: a systematic review and meta-analysis. Allergy. 2021 Apr;76(4):1053-76. Аннотация

90. Taylor K, Swan DJ, Affleck A, et al. Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists. Br J Dermatol. 2017 Jun;176(6):1617-23.Полный текст  Аннотация

91. Drucker AM, Ellis AG, Bohdanowicz M, et al. Systemic immunomodulatory treatments for patients with atopic dermatitis: a systematic review and network meta-analysis. JAMA Dermatol. 2020 Jun 1;156(6):659-67.Полный текст  Аннотация

92. Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007 May;21(5):606-19. Аннотация

93. Roekevisch E, Spuls PI, Kuester D, et al. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol. 2014 Feb;133(2):429-38. Аннотация

94. Gerbens LAA, Hamann SAS, Brouwer MWD, et al. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial. Br J Dermatol. 2018 Jun;178(6):1288-96. Аннотация

95. Schram ME, Roekevisch E, Leeflang MM, et al. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol. 2011 Aug;128(2):353-9.Полный текст  Аннотация

96. Li VCY, Chen KS, Yesudian BD. Subcutaneous methotrexate in the management of atopic dermatitis: a series of 12 patients. J Am Acad Dermatol. 2015 May 1;72(5 Suppl 1):AB75.

97. Weatherhead SC, Wahie S, Reynolds NJ, et al. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol. 2007 Feb;156(2):346-51. Аннотация

98. Goujon C, Bérard F, Dahel K, et al. Methotrexate for the treatment of adult atopic dermatitis. Eur J Dermatol. 2006 Mar-Apr;16(2):155-8. Аннотация

99. Dvorakova V, O'Regan GM, Irvine AD. Methotrexate for severe childhood atopic dermatitis: clinical experience in a tertiary center. Pediatr Dermatol. 2017 Sep;34(5):528-34.Полный текст  Аннотация

100. Sawangjit R, Dilokthornsakul P, Lloyd-Lavery A, et al. Systemic treatments for eczema: a network meta-analysis. Cochrane Database Syst Rev. 2020 Sep 14;9(9):CD013206.Полный текст  Аннотация

101. Phan K, Smith SD. Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis. J Dermatolog Treat. 2020 Dec;31(8):810-4. Аннотация

102. George SM, Karanovic S, Harrison DA, et al. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. Cochrane Database Syst Rev. 2019 Oct 29;2019(10):CD003871.Полный текст  Аннотация

103. Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999 Dec;135(12):1522-5.Полный текст  Аннотация

104. National Institute for Health and Care Excellence. Atopic eczema in under 12s: diagnosis and management. March 2021 [internet publication].Полный текст

105. Ferguson L, Futamura M, Vakirlis E, et al. Leukotriene receptor antagonists for eczema. Cochrane Database Syst Rev. 2018 Oct 21;10(10):CD011224.Полный текст  Аннотация

106. Pickett K, Loveman E, Kalita N, et al. Educational interventions to improve quality of life in people with chronic inflammatory skin diseases: systematic reviews of clinical effectiveness and cost-effectiveness. Health Technol Assess. 2015 Oct;19(86):1-176.Полный текст  Аннотация

107. Chisolm SS, Taylor SL, Balkrishnan R, et al. Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol. 2008 Oct;59(4):677-83. Аннотация

108. de Bes J, Legierse CM, Prinsen CA, et al. Patient education in chronic skin diseases: a systematic review. Acta Derm Venereol. 22011 Jan;91(1):12-7.Полный текст  Аннотация

109. Carbone A, Siu A, Patel R. Pediatric atopic dermatitis: a review of the medical management. Ann Pharmacother. 2010 Sep;44(9):1448-58. Аннотация

110. Wollenberg A, Blauvelt A, Guttman-Yassky E, et al. Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2). Br J Dermatol. 2021 Mar;184(3):437-49.Полный текст  Аннотация

111. National Institute for Health and Care Excellence. Baricitinib for treating moderate to severe atopic dermatitis. March 2021 [internet publication].Полный текст

112. Silverberg JI, Simpson EL, Thyssen JP, et al. Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis: a randomized clinical trial. JAMA Dermatol. 2020 Aug 1;156(8):863-73.Полный текст  Аннотация

113. Ruzicka T, Hanifin JM, Furue M, et al. Anti-Interleukin-31 receptor A antibody for atopic dermatitis. N Engl J Med. 2017 Mar 2;376(9):826-35.Полный текст  Аннотация

114. Kabashima K, Matsumura T, Komazaki H, et al. Trial of nemolizumab and topical agents for atopic dermatitis with pruritus. N Engl J Med. 2020 Jul 9;383(2):141-50.Полный текст  Аннотация

115. Renert-Yuval Y, Guttman-Yassky E. Systemic therapies in atopic dermatitis: The pipeline. Clin Dermatol. 2017 Jul - Aug;35(4):387-97. Аннотация

116. Lee DE, Clark AK, Tran KA, et al. New and emerging targeted systemic therapies: a new era for atopic dermatitis. J Dermatolog Treat. 2018 Jun;29(4):364-74. Аннотация

117. Chan S, Cornelius V, Cro S, et al. Treatment effect of omalizumab on severe pediatric atopic dermatitis: the ADAPT randomized clinical trial. JAMA Pediatr. 2020 Jan 1;174(1):29-37.Полный текст  Аннотация

118. Guttman-Yassky E, Blauvelt A, Eichenfield LF, et al. Efficacy and safety of lebrikizumab, a high-affinity interleukin 13 inhibitor, in adults with moderate to severe atopic dermatitis: a phase 2b randomized clinical trial. JAMA Dermatol. 2020 Apr 1;156(4):411-20.Полный текст  Аннотация

119. Kim BS, Howell MD, Sun K, et al. Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream. Allergy Clin Immunol. 2020 Feb;145(2):572-82.Полный текст  Аннотация

120. Kim BS, Sun K, Papp K, et al. Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study. J Am Acad Dermatol. 2020 Jun;82(6):1305-13.Полный текст  Аннотация

121. Nakagawa H, Nemoto O, Igarashi A, et al. Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis. J Allergy Clin Immunol. 2019 Dec;144(6):1575-83.Полный текст  Аннотация

122. Christoffers WA, Coenraads PJ, Svensson Å, et al. Interventions for hand eczema. Cochrane Database Syst Rev. 2019 Apr 26;4(4):CD004055.Полный текст  Аннотация

123. Illi S, von Mutius E, Lau S, et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol. 2004 May;113(5):925-31. Аннотация

124. British National Formulary. Skin infections, antibacterial therapy. 2021 [internet publication].Полный текст

125. Ersser SJ, Cowdell F, Latter S, et al. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev. 2014 Jan 7;(1):CD004054.Полный текст  Аннотация

126. Lavda AC, Webb TL, Thompson AR. A meta-analysis of the effectiveness of psychological interventions for adults with skin conditions. Br J Dermatol. 2012 Nov;167(5):970-9. Аннотация

127. Greenhawt M. The role of food allergy in atopic dermatitis. Allergy Asthma Proc. 2010 Sep-Oct;31(5):392-7. Аннотация

128. Chida Y, Steptoe A, Hirakawa N, et al. The effects of psychological intervention on atopic dermatitis: a systematic review and meta-analysis. Int Arch Allergy Immunol. 2007;144(1):1-9. Аннотация

129. Weber MB, Fontes Neto Pde T, Prati C, et al. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. J Eur Acad Dermatol Venereol. 2008 Aug;22(8):992-7. Аннотация